Finance

Beta
Lists
TSHA:NASDAQ
Taysha Gene Therapies Inc
$5.50
-6.62%
(-0.39) 1D
$5.68
+3.27% (+0.18)
Pre-market
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TSHA...
Open
$5.86
High
$5.94
Low
$5.44
Mkt. cap
1.58B
Avg. vol.
2.25M
Volume
25.00
52-wk high
$7.30
52-wk low
$2.25
EPS
-$0.38
Beta
1.19
Shares outstanding
287.36M
No. of employees
99
Open
$5.86
High
$5.94
Low
$5.44
Mkt. cap
1.58B
Avg. vol.
2.25M
Volume
25.00
52-wk high
$7.30
52-wk low
$2.25
EPS
-$0.38
Beta
1.19
Shares outstanding
287.36M
No. of employees
99
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to TSHA in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for TSHA in the last 3 months.
Highest
Current $5.50
$19.00 (+245.45%)
Average
$12.67 (+130.36%)
Lowest
$9.00 (+63.64%)
News stories
From sources across the web
About Taysha Gene Therapies Inc
CEO-
Employees99
Founded2019
HeadquartersDallas, Texas, United States
SectorBiotechnology
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.12 / -$0.10
-22.45%miss
Revenue / Est. (USD)
- / 758.33K
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.99M
-
5.48M
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.14M
25.74M
24.95M
33.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.60M
8.28M
8.83M
9.68M
Operating expense
28.74M
34.02M
33.78M
43.49M
Total operating expenses
28.74M
34.02M
33.78M
43.49M
Operating income
-26.75M
-34.02M
-28.30M
-43.49M
Other non operating income
-510.00K
-1.86M
3.76M
-31.00K
EBT including unusual items
-26.88M
-32.73M
-27.85M
-42.41M
EBT excluding unusual items
-25.42M
-32.73M
-21.68M
-40.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.88M
-32.73M
-27.85M
-42.41M
Net profit margin
-1,353.58%
-
-507.77%
-
Earnings per share
-0.08
-0.09
-0.07
-0.11
Interest and investment income
1.86M
3.17M
2.87M
2.59M
Interest expense
-17.00K
-15.00K
-12.00K
-9.00K
Net interest expenses
1.84M
3.15M
2.86M
2.58M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.48M
-33.74M
-28.00M
-43.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more